چكيده به لاتين
For years, innovation has been developed by Western companies, which have extensively introduced their innovations into developing countries and have gained these markets. However, there has recently been an increasing innovation in emerging companies in developing countries, which in turn seeks to transfer their products to developed countries. This trend is referred to as reverse innovation.
In this research, the effect of reverse innovation on the entry of developing countries into global markets has been studied. This research is applied in terms of purpose and descriptive type of collection method. The pharmaceutical industry has been selected as a case study. A questionnaire tool was used to measure the research variables and collect data. In the questionnaire, the reverse innovation factor was considered from three variables of the company's innovation capabilities, government support, and the social environment of innovation, which was considered through 19 questionable questions. Also, the factor for entering developing countries with global markets is 9 questions and reverse innovation with 5 questions. Validity of the questionnaire was verified through content validity, divergent and convergent. Reliability of the questionnaire was measured by Cronbach's alpha coefficients and its reliability. Among the statistical population, using a simple random sampling method, a questionnaire distributed among 150 experts in the pharmaceutical industry. Among the collected questionnaires, 108 non-defective questionnaires were analyzed and analyzed.
For data analysis, Excel 2010 and SPSS 22 software were used. According to non_normality of the data, the second-order structural equation or variance-axis (partial least squares-PLS) method was selected, for which purpose the soft Smart PLS 3 was used. Smart PLS software outlets point to the fact that reverse innovation has a positive and significant effect on the entry of developing countries into global markets.
